Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter Species
Open Access
- 28 January 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (2) , 185-190
- https://doi.org/10.1001/archinte.162.2.185
Abstract
RESISTANCE TO antimicrobial drugs is a growing health and economic concern. Rates of resistance in hospital-acquired gram-positive and gram-negative infections have risen dramatically over the past decade.1,2 Infections caused by resistant organisms are thought to result in higher morbidity and mortality, prolonged hospitalization, and increased costs compared with infections caused by sensitive strains; however, few studies have examined quantitatively the health and economic impact of the development of resistant organisms.Keywords
This publication has 7 references indexed in Scilit:
- National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, Issued June 1999American Journal of Infection Control, 1999
- Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosaArchives of internal medicine (1960), 1999
- Impact of Methicillin Resistance on the Outcome of Patients With Bacteremia Caused by Staphylococcus aureusArchives of internal medicine (1960), 1998
- Efficacy of Cefepime in the Treatment of Infections Due to Multiply Resistant Enterobacter SpeciesClinical Infectious Diseases, 1996
- Development of resistance byEnterobacter cloacae during therapy of pulmonary infections in intensive care patientsJournal of Molecular Medicine, 1994
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991
- Bacteremia Caused by Enterobacter: 15 Years of Experience in a Cancer HospitalClinical Infectious Diseases, 1991